ORASURE TECHNOLOGIES INC
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 9B. Other Information
a. None.
b. The following table discloses any director or “officer” as defined in Rule 16a-1(f) under the Exchange Act whoadopted orterminated any Rule 10b5-1 trading plan or arrangements or any non-Rule 10b5-1 trading plan or arrangements, in both cases as defined in Item 408(a) of Regulation S-K during the fourth quarter of the fiscal year ended December 31, 2025.
| Name and Title | Action Taken (Date of Action) | Type of Trading Arrangement | Nature of Trading Arrangement | Duration or End Date | Aggregate Number of Securities |
|---|---|---|---|---|---|
| Carrie Eglinton Manner President, Chief Executive Officer and Director | Adoption (November 29, 2025) | Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). | Purchase of the Company’s common stock pursuant to the terms of the plan. | Active through August 28, 2026 | Up to $165,000 of shares of the Company’s common stock |
| Kenneth McGrathChief Financial Officer | Adoption (November 28, 2025) | Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). | Purchase of the Company’s common stock pursuant to the terms of the plan. | Active through August 28, 2026 | Up to $165,000 of shares of the Company’s common stock |
Other than as disclosed above, no other director or officer adopted or terminated any Rule 10b5-1 trading plan or arrangements or any non-Rule 10b5-1 trading plan or arrangements, in both cases as defined in Item 408(a) of Regulation S-K during the fourth quarter of the fiscal year ended December 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.